These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Where vaptans do and do not fit in the treatment of hyponatremia. Jovanovich AJ; Berl T Kidney Int; 2013 Apr; 83(4):563-7. PubMed ID: 23254896 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of tolvaptan in patients hospitalized for heart failure with refractory hyponatremia. Clinical experience in daily practice. Salterain-Gonzalez N; Esteban-Fernández A; García-López M; Lavilla-Royo FJ; Gavira-Gómez JJ Rev Esp Cardiol (Engl Ed); 2013 Jun; 66(6):503-4. PubMed ID: 24776057 [No Abstract] [Full Text] [Related]
7. Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure. Sahu R; Balaguru D; Thapar V; Haque I; Pham-Peyton C; Bricker JT Tex Heart Inst J; 2012; 39(5):724-6. PubMed ID: 23109779 [TBL] [Abstract][Full Text] [Related]
8. Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Schrier RW; Masoumi A; Elhassan E Blood Purif; 2009; 27(1):28-32. PubMed ID: 19169014 [TBL] [Abstract][Full Text] [Related]
14. Hyponatremia and outcomes in patients with heart failure. Goldsmith SR Heart; 2012 Dec; 98(24):1761-2. PubMed ID: 23204533 [No Abstract] [Full Text] [Related]
15. Hyponatremia in heart failure: time for a trial. Goldsmith SR J Card Fail; 2013 Jun; 19(6):398-400. PubMed ID: 23743488 [No Abstract] [Full Text] [Related]
16. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure. Cyr PL; Slawsky KA; Olchanski N; Krasa HB; Goss TF; Zimmer C; Hauptman PJ Am J Health Syst Pharm; 2011 Feb; 68(4):328-33. PubMed ID: 21289328 [TBL] [Abstract][Full Text] [Related]
17. Vasopressin antagonists. Berl T N Engl J Med; 2015 Jun; 372(23):2207-16. PubMed ID: 26039601 [No Abstract] [Full Text] [Related]
18. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. Lin TE; Adams KF; Patterson JH Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436 [TBL] [Abstract][Full Text] [Related]
19. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Nemerovski C; Hutchinson DJ Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957 [TBL] [Abstract][Full Text] [Related]
20. [Hyponatraemia, antagonists of the antidiuretic hormone and cardiac failure]. de Groote P Arch Mal Coeur Vaiss; 2006 Mar; 99(3):215-20. PubMed ID: 16618024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]